Partnership with CliniOps results in digital, automated research suite
We are excited to announce the launch of our new TRUST platform to transform clinical trials. Formed in partnership with CliniOps, the platform helps digitize and automate trials from the study building phase to support decentralized, virtual and hybrid trial capabilities.
“Our goal at Stefanini Group is to use the latest digital technologies to transform life science business functions,” said Renata Galle, VP, Innovation & Digital Business. “Our TRUST platform unifies the trial process, eliminating multiple vendors and high costs to increase efficiency and improve RoI. We are thrilled to announce this partnership with CliniOps to help Sponsors and CROs execute smart trials.”
“The Platform will help increase collaboration, automation, enabling faster trials with increased compliance,” added Nagesh Jadhav, Director, Digital Transformation and Innovation for Life sciences. “With Digital and e-Clinical solutions, it brings more transparency, insights, visibility and audit readiness.”
The TRUST Platform is built on our Life Science Unit’s 20 years of experience in supporting Large and Mid-size Clients globally in Clinical Services. It is a unified platform consisting of e-clinical solutions from study startup to close out like Study Builder, Provisioning Services, and Smart and Virtual Trials. It has four pillars that focus on integration, automation, collaboration and compliance for clinical trials. With a digital design, the TRUST platform integrates with all other third party systems, devices and applications currently being used in clinical trials for more collaborative and faster trials.
Powered by our AI virtual assistant, ‘Sophie,’ the platform automates processes resulting in significant time and cost reduction, and ultimately faster trials. Sophie can act as Help Desk support, study manager, answer clinician queries and questions, gather information from social listening and retrieve documents to assist users. Sophie can also be integrated with internal and external sources such as ClinicalTrials.gov, PubMed and other custom public data sources.
“The outbreak of a global pandemic has put many trials on hold and accelerated the need for digital and remote data capabilities,” said Avik Pal, CEO, CliniOps. “New processes need to be adapted to restart trials and transform them moving forward. CliniOps is very excited to partner with Stefanini to address these challenges and bring an efficient solution to our valued customers.”
We offer organizations of all shapes and sizes a broad portfolio of digital transformation services and solutions, including industrial automation, cognitive computing, workplace of the future development, customer experience, business consulting, digital marketing and artificial intelligence.
To learn more about CliniTRUST, click here.
For CliniOps, visit https://cliniops.com/.
